Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Clear Channel Outdoor Holdings $750 million senior secured notes offering
The 9% notes are due 2028
Alight $180 million block trade
The stock is listed on the NYSE
Valaris $400 million senior secured second-lien notes offering
The high-yield senior secured second-lien notes are due 2030
Fiserv $2 billion notes offering
The investment-grade debt consists of two tranches of notes
Apollo Global Management $2.625 billion Arconic acquisition financing
We advised the agent and lenders on the financing
AN2 Therapeutics $70 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Akamai Technologies $1.1 billion convertible senior notes offering
The convertible senior notes are due 2029
Workiva $625 million convertible senior notes offering
The 1.25% convertible senior notes are due 2028
RAPT Therapeutics $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Shockwave Medical $750 million convertible senior notes offering
The 1% convertible notes are due 2028